More than just a city: Northbank Business Exchange realises Sarawak’s Health Metropolis vision
NiveshIQ
NSE: METROPOLIS · Healthcare
Metropolis Healthcare Ltd.
₹585.50▼ ₹10.15 (-1.70%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on METROPOLIS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Metropolis Healthcare Ltd.
Metropolis Healthcare Limited is a leading provider of pathology and related healthcare services in India and internationally, offering a wide range of diagnostic tests and services, including routine and specialised pathology tests, advanced diagnostics, and radiology services. The company's key revenue drivers include its pathology and diagnostic services, which cater to a diverse customer base, including direct-to-consumer diagnostics, partnerships with standalone labs and hospital chains, and institutional clients. In recent developments, Metropolis Healthcare's promoters have sold a 1% stake to institutions, and the company has seen investments from prominent entities such as Morgan Stanley, Aditya Birla Fund Life AMC, and ICICI Prudential AMC, with a total investment of ₹118 crore. T
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,207 Cr +5.10% | ₹1,331 Cr +10.30% | ₹1,646 Cr +23.70% |
| EBITDA Margin | 23.45% | 22.76% | 25.91% |
| Net Profit | ₹129.00 Cr -9.80% | ₹145.00 Cr +12.40% | ₹191.18 Cr +31.80% |
| EPS | ₹6.25 | ₹7.06 | ₹9.19 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Healthcare Stock With 40% Specialty Revenue and a Hard-to-Replicate Moat to Add to Your Watchlist
Get Your Mini-Metropolis On With Browser-Based City Builder Urbanitas
🔒
+ 3 more stories about Metropolis Healthcare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹450 Cr, PAT ₹57 Cr, EPS ₹2.73, EBITDA margin 25.8%. Growth context: revenue QoQ +6.0%, PAT QoQ +11.6%. Street verdict: inline, revenue surprise +0.9%, PAT surprise +3.5%.
Test volumes, test mix, B2B/reference-lab traction, pricing discipline, and operating leverage remain the key forward dr...
FY26 (last completed FY): revenue ₹1, 646 Cr, PAT ₹191 Cr, EBITDA margin 25.9%, EPS ₹9.19. Year-on-year: revenue YoY +23...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for METROPOLIS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track METROPOLIS alongside your other holdings
Unlock full METROPOLIS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Metropolis Healthcare Ltd.?
NiveshIQ detects active intelligence signals for Metropolis Healthcare Ltd. (METROPOLIS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Metropolis Healthcare Ltd.?
Metropolis Healthcare Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,138,229.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.